6Gunderson LL, Sosin H. Adenocarcinoma of the stomach:areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy [J]. Int J Radiat Oncol Biol Phys, 1982,8(1): 1-11.
7Douglass Ho. Gastric cancer: overview of current therapies [J].Semin Oncol, 1985,12(3) :57-62.
8Ikeguchi M, Oka A, Tsujitani S, et al. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer [J]. Anticancer Res, 1994,14(5B) :2131-2134.
9Yu W. Intraperitoneal 5-fluorouracil and mitomycin C as adjuvants to resectable gastric cancer: a status report [J]. Cancer Treat Res, 1996,81: 177-183.
10Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery [J]. Cancer, 1997,79 (5): 884-891.
